56S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sartorius Stedim Biotech SA

Watchlist Manager

Watchlist

Price: 160.1 EUR -12.18% Market Closed

Market Cap: €38.6B

S	Sartorius Stedim Biotech SA SWB:56S1	FR
	Altair International Corp OTC:ATAO	US
	Orthocell Ltd ASX:OCC	AU
Z	Zalando SE F:ZAL	DE
P	Polytec Holding AG VSE:PYT	AT
S	Southern Energy Corp LSE:SOUC	CA
A	Asep Medical Holdings Inc CNSX:ASEP	CA
	Oryzon Genomics SA MAD:ORY	ES
R	Rambus Inc XMUN:RMB	US

Profitability Summary

Sartorius Stedim Biotech SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

45%

Sustainable 3Y Average Gross Margin

46%

Declining Gross Margin

52% > 45%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

26% > 18%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

21% > 9%

Exceptional Free Cash Flow Margin

12%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

4% > 12%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.